Alpha-1 Antitrypsin Deficiency Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
Condition: Pulmonary Emphysema in Alpha-1 Antitrypsin DeficiencyIntervention: Biological: Alpha-1 MPSponsor: Grifols Therapeutics Inc.Enrolling by invitation - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2016 Category: Research Source Type: clinical trials
